BEFORE THE 

U.S. DEPARTMENT OF TRANSPORTATION 

OFFICE OF THE SECRETARY 

WASHINGTON, D.C. , i! y ! lt I l 

) 

Motion of ) 

) 

US AIRWAYS, INC. ) 

) 

for confidential treatment of documents pursuant ) 

to Rule 12 of the Rules of Practice ) 

(Schedule B-7 of Form 41) ) 

) _______________________________ ) 

Docket OST -96-1826 

(former Docket 48735) 

. MOTION OF US AIRWAYS, INC. 

FOR CONFIDENTIAL TREATMENT 

Communications with respect to this document should be sent to: 

Howard Kass 

Vice President - Legal and Government Affairs 

Benjamin T. Slocum 

Director and Assistant General Counsel 

US Airways, Inc. 

1401 H Street, NW, Suite 1075 

Washington, DC 20005 

(202) 326-5153 

howard.kass@usairways.com 

benjamin.slocum@usairways.com 

May 10,2012 
BEFORE THE 

U.S. DEPARTMENT OF TRANSPORTATION 

OFFICE OF THE SECRETARY 

WASHINGTON, D.C. 

) 

Motion of ) 

) 

US AIRWAYS, INC. ) 

) 

for confidential treatment of documents pursuant ) 

to Rule 12 of the Rules of Practice ) 

(Schedule B-7 of Form 41) ) 

) _______________________________) 

May 10,2012 

Docket OST -96-1826 

(former Docket 48735) 

MOTION OF US AIRWAYS, INC. 

FOR CONFIDENTIAL TREATMENT 

Pursuant to Rule 12 of the Department's Rules of Practice (14 C.P.R. § 302.12), 

US Airways, Inc. ("US Airways") hereby requests confidential treatment ·of certain information 

contained in Schedule B-7 - Airframe and Aircraft Engine Acquisitions and Retirements of 

US Airways' Form 41 filing for the quarter ended March 31,2012 ("Schedule B-7"). That filing 

will be submitted separately herewith under seal, marked with a request for confidential 

treatment pursuant to Rule 12 (§ 302.12). US Airways requests that these data be withheld from 

public disclosure for a period of at least ten (1 0) years from the date of their submission. In 

support of this request, US Airways states as follows: 

The Freedom of Information Act, 5 U.S.C. § 552(b)(4), provides that confidential 

commercial and financial information obtained from a private person is exempt from the 

requirements of public disclosure. The information for which US Airways requests confidential 

treatment is confidential and proprietary commercial and financial information obtained from 

US Airways, a private party. Moreover, the public release of that information would cause US 

2 
Motion of US Airways, Inc. for Confidential Treatment 

Airways substantial competitive and financial injury. Accordingly, the information should be 

withheld from public disclosure. 

The information at issue is cost, amortization/depreciation and realization data relating to 

US Airways' airframes and aircraft engines as of March 31, 2012. This information is presented 

in columns 10, 11, and 12 of Schedule B-7. See Exhibit A hereto for a listing of the specific 

information included in Schedule B-7 for which confidential treatment is requested. In addition 

to filing Schedule B-7 under seal, US Airways is submitting to the Office of Aviation Analysis 

redacted copies of Schedule B-7, available for public inspection, that omit the information for 

which confidential treatment is requested. 

The Department has previously determined that the confidential and competitivelysensitive data contained in US Airways' Schedules B-7 are entitled to confidential treatment. By 

letter of James W. Mitchell, Director, Office of Airline Statistics, the Department granted prior 

US Airways' requests for confidential treatment of this same information for earlier reporting 

periods and ruled that it be withheld from public disclosure for a period of ten (1 0) years. The 

Department's reasoning applies with equal force to US Airways' present motion and submission. 

3 
Motion of US Airways, Inc. for Confidential Treatment 

WHEREFORE, US Airways respectfully requests that the confidential information 

contained in its Schedule B-7 detailed above be withheld from public disclosure for at least ten 

(10) years. 

Respectfully submitted, 

How dKass 

Vice President - Legal and Government Affairs 

Benjamin T. Slocum 

Director and Assistant General Counsel 

US Airways, Inc. 

1401 H Street, NW, Suite 1075 

Washington, DC 20005 

(202) 326-5153 

howard.kass@usairways.com 

benjamin.slocum@usairways.com 

May 10,2012 

4 
.. 

EXHIBIT A 

Listing of Confidential Information in US Airways, Inc.'s Form 41 Filing 

Schedule B-7: 

Title/DescriQtion Location in Document Number of Pages 

Cost Column (10) 1 

Depreciated Cost or Column (11) 1 

Amortized Value 

Realization Column (12) 1